BDBM423461 WO2006061714-ID-03
SMILES: COC(O)[C@@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
InChI Key: InChIKey=GYPAMRSUOHRGGS-BCKKPBOXSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM423461 (WO2006061714-ID-03) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | WIPO | n/a | n/a | n/a | n/a | 800 | n/a | n/a | n/a | n/a |
Pfizer Inc. | Assay Description Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ... | WIPO (2005) BindingDB Entry DOI: 10.7270/Q2PV6NRF | |||||||||||
More data for this Ligand-Target Pair |